Deubiquitinating enzymes as novel anticancer targets
Benjamin Nicholson1, Jeffrey G Marblestone, Tauseef R Butt
1Progenra, Inc., 271A Great Valley Parkway, Malvern, PA 19355, USA. nicholson@progenra.com
Future Oncology (London, England)
|March 27, 2007
Summary
Deubiquitinases (DUBs) regulate protein lifespan and localization, impacting cell growth. Targeting these enzymes offers a promising strategy for developing novel anticancer therapies by modulating oncogenes and tumor suppressors.
Area of Science:
- Biochemistry and Molecular Biology
- Cellular Regulation
- Oncology
Background:
- Protein ubiquitination is a key regulatory mechanism controlling protein stability and localization in eukaryotic cells.
- Deubiquitinases (DUBs) are enzymes that remove ubiquitin tags, counterbalancing the action of ubiquitin ligases.
- Dysregulation of the ubiquitin-proteasome system is implicated in various cancers.
Purpose of the Study:
- To review the multifaceted roles of deubiquitinases (DUBs) in cellular physiology.
- To explore the therapeutic potential of targeting DUBs in cancer treatment.
- To identify specific DUBs as viable targets for anticancer drug discovery.
Main Methods:
- Review of existing literature on ubiquitin pathway enzymes and their roles in cell regulation.
- Analysis of the human proteome to identify functional deubiquitinases (DUBs).
- Consideration of DUBs as molecular oncology targets for drug development.
Main Results:
- There are approximately 79 functional deubiquitinases (DUBs) in the human proteome.
- DUBs play critical roles in regulating protein turnover and localization, influencing cell growth and physiology.
- Selective targeting of DUBs presents a viable therapeutic strategy in oncology.
Conclusions:
- Deubiquitinases (DUBs) are essential regulators of cellular processes and are implicated in cancer.
- Targeting specific DUBs can modulate oncogene activity or stabilize tumor suppressors.
- DUBs represent a promising class of enzymes for the development of novel anticancer therapeutics.
Related Concept Videos
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...